Coronavirus may be safely treated with recovered patients' plasma, study shows


A not-yet-peer-reviewed study seems to pave the way for treating coronavirus with plasma from recovered patients.
With no treatments approved for treating COVID-19 yet, doctors around the country have been trying a variety of drugs and therapies in hopes of finding something promising and further studying it. One of those experimental treatments, known as convalescent plasma transfusions, appears to be safe and could be a worthwhile treatment after it's studied more, an unreviewed study published Thursday on a public server called Medrxiv suggests.
Researchers at the Mayo Clinic, Michigan State University, and Johns Hopkins University, looked at 5,000 coronavirus patients around the country who received convalescent plasma transfusions from recovered patients, The Wall Street Journal notes via the study. Under one percent of the treated patients saw "serious adverse effects" after the transfusions, and there was a 14.9 percent mortality rate seven days after transfusions. Two-thirds of these patients were critically ill to begin with, so "the mortality rate does not appear excessive," the study said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
While this study doesn't determine whether convalescent transfusions effectively treat coronavirus, it does suggest they are safe for wider research. This study will need to be peer reviewed and replicated in official medical journals before it can be considered an approved way of treating COVID-19. The Food and Drug Administration did approve the "compassionate use" of convalescent plasma treatments in emergency situations as part of its attempts to find an effective therapy.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.
-
Can Texas redistricting save the US House for the GOP?
Today's Big Question Trump pushes a 'ruthless' new plan, but it could backfire
-
'No one should be surprised by this cynical strategy'
Instant Opinion Opinion, comment and editorials of the day
-
Intellectual property: AI gains at creators' expense
Feature Two federal judges ruled that it is fair use for AI firms to use copyrighted media to train bots
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths